Hidaka T - Search Results

1

GITR cosignal in ILC2s controls allergic lung inflammation.

Nagashima H, Okuyama Y, Fujita T, Takeda T, Motomura Y, Moro K, Hidaka T, Omori K, Sakurai T, Machiyama T, Ndhlovu LC, Riccardi C, So T, Ishii N. Nagashima H, et al. Among authors: hidaka t. J Allergy Clin Immunol. 2018 May;141(5):1939-1943.e8. doi: 10.1016/j.jaci.2018.01.028. Epub 2018 Feb 8. J Allergy Clin Immunol. 2018. PMID: 29427641 No abstract available.

2

Environmental pollutants and the immune response.

Suzuki T, Hidaka T, Kumagai Y, Yamamoto M. Suzuki T, et al. Among authors: hidaka t. Nat Immunol. 2020 Dec;21(12):1486-1495. doi: 10.1038/s41590-020-0802-6. Epub 2020 Oct 12. Nat Immunol. 2020. PMID: 33046888 Review.

3

Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell Carcinoma.

Sato Y, Fujimura T, Hidaka T, Lyu C, Tanita K, Matsushita S, Yamamoto M, Aiba S. Sato Y, et al. Among authors: hidaka t. Front Immunol. 2020 Oct 16;11:534323. doi: 10.3389/fimmu.2020.534323. eCollection 2020. Front Immunol. 2020. PMID: 33178182 Free PMC article.

4

The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin.

Hidaka T, Ogawa E, Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Fujimura T, Aiba S, Nakayama K, Okuyama R, Yamamoto M. Hidaka T, et al. Nat Immunol. 2017 Jan;18(1):64-73. doi: 10.1038/ni.3614. Epub 2016 Nov 21. Nat Immunol. 2017. PMID: 27869817

5

Sequential Therapy with Nivolumab Followed by Ipilimumab Induces Complete Response in Metastatic Melanoma of the Lung but with Severe Hepatotoxicities.

Furudate S, Fujimura T, Kambayashi Y, Hidaka T, Hashimoto A, Aiba S. Furudate S, et al. Among authors: hidaka t. Case Rep Oncol. 2016 Oct 17;9(3):644-649. doi: 10.1159/000450974. eCollection 2016 Sep-Dec. Case Rep Oncol. 2016. PMID: 27920696 Free PMC article.

6

Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer.

Fujimura T, Kambayashi Y, Fujisawa Y, Hidaka T, Aiba S. Fujimura T, et al. Among authors: hidaka t. Front Oncol. 2018 Jan 23;8:3. doi: 10.3389/fonc.2018.00003. eCollection 2018. Front Oncol. 2018. PMID: 29410946 Free PMC article. Review.

7

Malassezia-derived aryl hydrocarbon receptor ligands enhance the CCL20/Th17/soluble CD163 pathogenic axis in extra-mammary Paget's disease.

Sato Y, Fujimura T, Tanita K, Chunbing L, Matsushita S, Fujisawa Y, Otsuka A, Yamamoto Y, Hidaka T, Aiba S. Sato Y, et al. Among authors: hidaka t. Exp Dermatol. 2019 Aug;28(8):933-939. doi: 10.1111/exd.13944. Epub 2019 Jun 6. Exp Dermatol. 2019. PMID: 31001887

8

Dermoscopy findings of pseudolymphomatous folliculitis.

Fujimura T, Hidaka T, Hashimoto A, Aiba S. Fujimura T, et al. Among authors: hidaka t. Case Rep Dermatol. 2012 May;4(2):154-7. doi: 10.1159/000341194. Epub 2012 Jul 12. Case Rep Dermatol. 2012. PMID: 22807900 Free PMC article.

9

Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget disease by receptor activator of nuclear factor kappa B (RANK) ligand/RANK pathways.

Fujimura T, Kambayashi Y, Furudate S, Kakizaki A, Hidaka T, Aiba S. Fujimura T, et al. Among authors: hidaka t. Br J Dermatol. 2017 Feb;176(2):387-394. doi: 10.1111/bjd.14864. Epub 2016 Dec 22. Br J Dermatol. 2017. PMID: 27411503

10

BRAF kinase inhibitors for treatment of melanoma: developments from early-stage animal studies to Phase II clinical trials.

Fujimura T, Hidaka T, Kambayashi Y, Aiba S. Fujimura T, et al. Among authors: hidaka t. Expert Opin Investig Drugs. 2019 Feb;28(2):143-148. doi: 10.1080/13543784.2019.1558442. Epub 2018 Dec 16. Expert Opin Investig Drugs. 2019. PMID: 30556435 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

868 results

Search Page